DS-5573a
Phase 1Terminated 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Solid Malignant Tumors
Conditions
Advanced Solid Malignant Tumors
Trial Timeline
Sep 1, 2014 → Jan 1, 2017
NCT ID
NCT02192567About DS-5573a
DS-5573a is a phase 1 stage product being developed by Daiichi Sankyo for Advanced Solid Malignant Tumors. The current trial status is terminated. This product is registered under clinical trial identifier NCT02192567. Target conditions include Advanced Solid Malignant Tumors.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02192567 | Phase 1 | Terminated |
Competing Products
20 competing products in Advanced Solid Malignant Tumors